M&A Deal Summary

Click Therapeutics Acquires Better Therapeutics

On May 22, 2024, Click Therapeutics acquired life science company Better Therapeutics

Acquisition Highlights
  • This is Click Therapeutics’ 1st transaction in the Life Science sector.
  • This is Click Therapeutics’ 1st transaction in the United States.
  • This is Click Therapeutics’ 1st transaction in California.

M&A Deal Summary
Date 2024-05-22
Target Better Therapeutics
Sector Life Science
Buyer(s) Click Therapeutics
Deal Type Add-on Acquisition

Target

Better Therapeutics

San Francisco, California, United States
Better Therapeutics is a prescription digital therapeutics (PDT) company delivering a novel form of behavior-based therapy to address the root causes of cardiometabolic diseases. Better Therapeutics has developed a proprietary platform for the development of FDA-regulated, software-based therapies for type 2 diabetes, heart disease, and other conditions. The cognitive-behavioral therapy delivered by Better Therapeutics’ PDT enables changes in neural pathways of the brain so lasting changes in behavior to become possible. Better Therapeutics was incorporated in 2015 and is based in San Francisco, California.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Click Therapeutics

New York, New York, United States
Category Company
Founded 2012
Sector Software
DESCRIPTION

Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click Therapeutics was founded in 2012 and is based in New York, New York.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal